[68Ga]Ga DOTA-5G

N/A

Report date: 2026/02/28 20:00:37

Base Information

Drug Name[68Ga]Ga DOTA-5G
Drug Alias Name[68Ga]Ga DOTA-5G
ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionPositron-emission tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungLeukemia, Myelogenous, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of California DavisUnited States Department Of Defense
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of California DavisUnited States Department Of Defense
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungLeukemia, Myelogenous, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A